Jump to content
MyTime

Welcome to our center for all the latest content and information. We encourage you to register in order to connect to the topics and communities that matter most to you.

Recent Announcements

  1. The National 988 Suicide Lifeline Has Launched - Here’s How It Works

    The National Suicide Prevention Lifeline is available nationwide! If you or someone you know is experiencing a mental health crisis, text or call 9-8-8 to get assistance and support from trained counselors or help with finding local resources.
    By Roger Murray
  2. Telemynd Achieves HITRUST CSF® Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements

    HITRUST CSF Certification validates Telemynd is committed to meeting key regulations and protecting sensitive information.
    Maynard, Massachusetts, December 6, 2021 – Telemynd, a leading provider of behavioral health solutions, today announced the MyCare telebehavioral health solution has earned Certified status for information security by HITRUST.
    HITRUST CSF Certified status demonstrates that the organization’s MyCare telebehavioral health solution has met key regulations and industry-defined requirements and is appropriately managing risk. This achievement places Telemynd in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards, and frameworks, and incorporating a risk-based approach, the HITRUST CSF helps organizations address these challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.
    “Organizations, like ours, are under more pressure than ever to meet complex compliance and privacy requirements that include technical and process elements such as NIST, ISO, and COBIT,” said Patrick Herguth, Chief Executive Office at Telemynd. “We are pleased to demonstrate to our customers the highest standards for protecting sensitive data and information by achieving HITRUST CSF Certification.”
    “The HITRUST CSF Assurance Program is the most rigorous available, consisting of a multitude of quality assurance checks, both automated and manual,” said Bimal Sheth, Vice President of Assurance Services, HITRUST. “The fact that Telemynd has achieved HITRUST CSF Certification attests to the high quality of their information risk management and compliance program.”
     About Telemynd
    141 Parker Street, Suite 306
    Maynard, MA 01754
    (866)991-2103
    Telemynd Media Contact                                                   
    Roger Murray
    Marketing Director
    rmurray@telemynd.com
    By Roger Murray
  3. Choosing Between A Prescriber Or Therapist?

    Both therapists and prescribers work with you to help improve your mental health, but they offer vastly different services. If you’ve decided it’s time to see a provider but you’re not sure what kind of support you need, read this guide to find out which could be the best fit for you.
    Therapist or Prescriber — Which Is Right For Me?
    By Roger Murray

Recent Blog Entries

  1. Telemynd Earns Spot on Glassdoor Best Place to Work in 2023

    Telemynd is pleased to announce we are among the winners of the annual Glassdoor Employees’ Choice Awards, a list of the Best Places to Work in 2023.
    Unlike other workplace awards, there is no self-nomination or application process, instead it’s entirely based on the feedback our team has voluntarily and anonymously shared on Glassdoor. To determine the winners of the awards, Glassdoor evaluates company reviews shared by current and former team members over the past year. This year, we are proud to be recognized as a Best Place to Work among U.S. companies with fewer than 1,000 team members.
    A huge thank you goes out to everyone on our team who took the time to share their perspective on what it’s like to work here. We appreciate all the valuable feedback as it only helps us improve.
     A Statement from Telemynd CEO, Patrick Herguth
    "As a people-first organization, we are proud to be recognized by our employees and behavioral health providers as being a place they choose to spend their valuable time. We know that high-quality behavioral health always starts with a person. The Telemynd team - from the patient service representatives on the phone helping our clients, to the clinicians providing these valuable services, to the billing team that helps a patient navigate the complexity of their insurance plans – is a mission-driven group that shows up every day to make a difference. This is recognition for everyone on the team and a testament to the culture we have built."
     
    Below are just a few words employees shared on Glassdoor that contributed toward the award and make us feel incredibly honored
     
    Innovative and Supportive, Clinical Care Manager 
    “Telemynd has been incredibly supportive since I started about a year and a half ago. They are a company who cares about their clients, employees and care providers. Genuinely interested in making their own footprint in the teletherapy world and bridging gaps in underserved communities. While the company may be virtual it feels anything but. Everyone is very connected and there is an emphasis on human connection and that personal touch.”
    Best Company I Have Worked For, Mental Health Clinician
    “Develop your own schedule. Once the Client is assigned, you reschedule yourself keeping your clients happy as you can choose if you want to work outside of the hours you posted to the scheduling department. Pay is very reasonable and as with any self-employed position it takes a while to build your caseload, so expect it. The pay has always been on time and I have found no inaccuracies. The advertisements are accurate, not like some platforms, that offer a certain amount per hour and then in the fine print only pay you the advertised amount when you work over a certain amount of hours. Support staff are professional, polite and extremely helpful. Also the medication providers can see your documentation and you can see theirs! This is such a plus, to keep the team running efficiently. BRAVO TELEMYND.”
    Professional and Pleasant Working Environment, Licensed Marriage and Family Therapist
    “I very much enjoy working with Telemynd as an independent contractor, very professional and caring staff, quick response to questions, very supportive to both patients and therapists, I highly recommend this company to those who have the love and passion for treating patients toward their healing process.”
    Great Work/Life Balance, Licensed Clinical Social Worker
    “I love working for Telemynd! The people are great and I am able to schedule my own appointments and see as many clients or as few as I wish. I am not stuck in an 8-6 setting seeing clients every hour and then working until late at night to get my notes done (sound familiar?). If you value your work/life balance and want to work for a company that truly appreciates your contribution to the mental health field, please consider Telemynd.”
  2. Controlled Substance Prescriptions in Telehealth: Q &A

    Controlled substances are used to treat many common mental health conditions, like anxiety, depression, sleep disorders, and more. Prior to the COVID-19 pandemic and national health emergency, federal rules regulated how these meds were prescribed and dispensed - including a requirement for an in-person health evaluation prior to a prescription being written. However, during the pandemic, federal regulators temporarily waived these regulations to permit patients the ability to manage their medication and access to prescriptions, including controlled substances via telehealth visits. 
    With the national health emergency waivers expected to expire soon, some states have stepped in to draft their own medication management legislation; the result has been growing confusion over which rules apply and where. In this article, we attempt to answer all your questions about prescribing controlled substances, and have included resources to find out more.
    Why are Some Medications Deemed Controlled Substances?
    Controlled substances by definition are medications with a likelihood for physical or mental dependence. Many of the more common drugs for ADHD, anxiety, sleep disorders, depression, and more, such as Xanax, Klonopin, Lunesta, and Adderall are listed as ‘controlled substances”. The U.S. Controlled Substances Act (1970) puts all substances which were in some manner regulated under existing federal law into one of five schedules. This placement is based on the substance’s medical use, its potential for abuse, and safety or dependence liability. Medications listed as Schedule I have the tightest controls, and those listed as Schedule V have the least restrictive controls. These controls are mandated by the federal government.
    This may all sound complicated - but it boils down to prescribers and pharmacies taking extra precaution to ensure these medications are prescribed for and delivered to the right individuals, for the right reasons.
    What Are the Extra Steps Clinicians Must Take to Prescribe Meds that are Deemed Controlled Substances?
    In general, to prescribe a controlled substance, a clinician must have a DEA (Drug Enforcement Administration) license, and to fill a prescription, a pharmacist must also have a controlled substance license. Further, for a pharmacist to dispense a controlled substance, the prescription must include specific information such as date of issue, patient’s name, address, and DoB, clinician name, address and DEA number, drug strength, number of refills, and the signature of the prescriber. For these kinds of medications, there are also legal limits on the number of refills and the amount that a prescription may contain. Some drugs have zero refills, and the maximum quantity dispensed is 30 days - meaning patients must contact their clinician each month a refill is needed.
    In addition, the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 specified that “any practitioner issuing a prescription for a controlled substance must conduct an in-person medical evaluation. A conservative recommendation to support compliance with the act is to conduct an in-person exam at least once every 24 months.”
    How did the COVID-19 Pandemic Impact Prescriptions of Controlled Substances?
    The unprecedented public health emergency created by COVID-19 caused action by state and federal regulators to ensure greater access to health care, while simultaneously limiting the spread of the virus. Therefore, as of March 2020, the DEA declared that practitioners “may issue prescriptions for controlled substances to patients via telemedicine, even for patients for whom they have not conducted an in-person medical evaluation, provided the prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of their professional practice, the telemedicine communication is conducted using an audiovisual, real-time, two-way interactive communication system, and the practitioner is acting in accordance with applicable federal and state laws.” At that time, the DEA also ruled it was “permissible to write controlled substance prescriptions to cover a 90-day supply.”
    However, depending on where you live or who prescribes your meds, you may have had a different experience as certain states and practitioners elected to retain pre-COVID protocols of in-person evaluations given the sensitivity of the medication being administered.  
    What is the Current Status of Controlled Substances Prescriptions?
    As we move through 2022 and the threat of COVID-19 has lessened, requirements for prescribing and dispensing controlled substances in some states have begun making permanent changes to expand policies implemented under the public health emergency, while others have passed laws restricting them. This website has made an attempt to track these ongoing changes - but to be safe, always check with your own state’s official website, or contact your state or federal representatives. 
    The DEA at the federal level said in a March press release, that it “wants medication-assisted treatment to be readily and safely available to anyone in the country who needs it."  However, in the end it is up to each state and provider to do what they feel is best for the safety of constituents and/or patients. Therefore, check with your provider or prescriber to find out if you will need an in-person visit to continue receiving prescriptions of controlled substances or if telehealth visits are an option for you. Telemynd operates as a national practice, meaning that our national network of licensed providers may prescribe many types of medications, they follow federal regulation which prevents the prescribing of controlled-substances via our virtual telemedicine environment. 
    Sources
    DEA.gov: Rules for Control Substances
    NIH | National Library of Medicine: Pharmacy Prescription Requirements
  3. Does Renaming a Mental Illness Change the Stigma?

    Erratic. Volatile. Complicated. These are the unfortunate words that people often think of when they think of someone with a diagnosis of schizophrenia - which in turn has caused a stigma that has lead to fear and isolation for those most vulnerable. A movement has developed, made up of scientists, medical professionals, mental health advocates, and those with the diagnosis, to change the name. In this week’s article, we’ll look at the pros and cons of the name change proposition as well as explain what led to the idea in the first place.
    What is Schizophrenia?
    Schizophrenia is a brain disorder that affects less than 1% of the population. When it’s in its ‘active phase’, symptoms can include delusions, hallucinations, disorganized speech, trouble with thinking, and lack of motivation. Research has shown that schizophrenia affects men and women fairly equally but may have an earlier onset in males. As with any illness, the severity, duration and frequency of symptoms can vary. The symptoms are why Dr. Eugen Bleuler named the disorder in 1908 - the term ‘schizophrenia’ derives from Greek words for “split mind” - because Dr. Bleuler thought the disease was characterized by a “splitting of psychological functions” where “the personality loses its unity.” But it turns out the condition was named erroneously.
    Researchers believe that a number of genetic and environmental factors contribute to the cause of schizophrenia, as well, life stress may also play a role in the start of symptoms. But since multiple factors may contribute, scientists aren’t yet sure of the exact cause in each individual case.
    Modern Treatment Means Symptoms are Very Manageable
    While there is no cure for schizophrenia, the good news is that research has led to innovative and safe treatments which means most symptoms will greatly improve and the likelihood of  recurrence is diminished. A combination of pharmaceutical treatment and therapeutic treatments such as cognitive behavioral therapy or supportive psychotherapy may reduce symptoms and enhance functioning. Additional treatments are aimed at reducing stress, supporting employment, and improving social skills.
    Yet a Stigma Still Exists
    So even while treatment helps dissipate symptoms, the complexity of schizophrenia may help explain why there are misconceptions about the disease. Contrary to what Dr. Bleuler thought when he named the disease over one hundred years ago, schizophrenia does not result in split personalities or multiple personalities. Most people with schizophrenia are no more dangerous than people in the general population. However, you’d never know this based on how people with the diagnosis are portrayed in TV, film, and other media. And as with most stigmas around mental health issues, stigmas perpetuate fear, make “others” out of those with the diagnosis, and in turn encourage isolation - all of which worsen the lives of already vulnerable individuals. Research has found that “public, anticipated, and self-stigma decrease healthcare seeking and treatment adherence, and create barriers to pursuing independent living” for those living with the condition..
    Would a Name Change Help Reduce the Stigma?
    This is how the idea of renaming schizophrenia came about. Said a recent New York Times article, "The idea is that replacing the term ‘schizophrenia’ with something less frightening and more descriptive will not only change how the public perceives people with the diagnosis but also how people with the diagnosis see themselves." Japan and South Korea have already changed the name to “Integration Disorder '', which is the term for which many in the re-naming movement are advocating.
    Most of the mental health community is behind the name change. A survey by the World Psychiatric Association showed that approximately half of mental health professionals around the world believe schizophrenia needs a new label, and over half believe the term is stigmatizing. Another 2021 poll found that 74% of stakeholders (mental health professionals, family members, researchers, government officials, and more) found the name stigmatizing and favored a name change.
    In the Meantime, How Can We Help Reduce the Stigma?
    Regardless of where you stand on the name change, the most important thing is to understand that schizophrenia is a physical disease of the brain - and like other medical diseases - it is treatable today. Much research has been done on how to reduce the stigma around this diagnosis, and that research has found that if we commit to educating society about schizophrenia, promote accurate representations of schizophrenia, and prioritize advocacy, we may help reduce the stigma.
    Sources
    The New York Times: ‘Schizophrenia’ Still Carries a Stigma. Will Changing the Name Help?
    American Psychiatric Association: What is Schizophrenia?
    National Alliance for Mental Illness: The Consequences of Stigma Surrounding Schizophrenia
    Schizophrenia Bulletin: Reducing Stigma Toward Individuals With Schizophrenia Using a Brief Video: A Randomized Controlled Trial of Young Adults

Latest Handouts

×
×
  • Create New...